Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

Stan & Jean Perron Awards supporting outstanding child health researchers

We are pleased to announce latest recipients of the Stan and Jean Perron Awards, that recognise the work of exceptional postgraduate students who are undertaking their research projects at The Kids Research Institute Australia.

News & Events

Kids researchers using real tonsils in quest to develop new Strep A vaccine

A new study underway at the Wesfarmers Centre of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, is deliberately infecting tonsils with Strep A in the laboratory to test a range of potential vaccine candidates.

News & Events

New cultural safety initiative guides best practice for clinical research

Perth investigators involved in a major global trial have launched an innovative Cultural Information Hub to maximise cultural safety for Aboriginal and/or Torres Strait Islander patients participating in research.

Research

ARIEL study

This study will test the hypothesis that the mechanisms of childhood asthma begin in the respiratory tract as early as birth.

Research

AusVaxSafety

Christopher Peter Peter Tom Blyth Jacoby Richmond Snelling MBBS (Hons) DCH FRACP FRCPA PhD BA (Hons) MSc MBBS MRCP(UK) FRACP BMBS DTMH GDipClinEpid

Research

Characterising the epidemiology of RSV in Australian children through record linkage: clinical burden, outcomes and risk factors

Hannah Peter Moore Richmond OAM BSc (Hons) GradDipClinEpi PhD MBBS MRCP(UK) FRACP Head, Infectious Diseases Research Head, Vaccine Trials Group 08

Meet the Trial Management Team

Meet the team behind the CIRCA DIEM study.

The CIRCA DIEM Sub-Studies

A sub-study is an ‘add-on’ study that helps to answer specific questions within a larger research project. If you decide to participate in the CIRCA DIEM study, you or your child may be invited to take part in one of the CIRCA DIEM sub-studies.

Research

COMBAT CF: A phase 3 multi-centre randomized placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis.

A phase 3 multi-centre randomized placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis